{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:33:56Z","timestamp":1793126036683,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejps.2026.107677","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:32:40Z","timestamp":1790922760000},"page":"107677","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Addressing good manufacturing practice challenges in hospital advanced therapy medical product facilities: A risk-based environmental microbiological monitoring approach"],"prefix":"10.1016","volume":"227","author":[{"given":"Sara","family":"Castiglia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Rustichelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Sismondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aloe","family":"Adamini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Mandese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Sinicropi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Fumagalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Mareschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franca","family":"Fagioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4364-8021","authenticated-orcid":false,"given":"Ivana","family":"Ferrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejps.2026.107677_bib0001","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1472-765X.2006.02095.x","article-title":"Environmental microbial contamination in a stem cell bank","volume":"44","author":"Cobo","year":"2007","journal-title":"Lett. Appl. Microbiol."},{"key":"10.1016\/j.ejps.2026.107677_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1579161","article-title":"UV-C and hydration state drive pulsed light-induced proteome damage in Bacillus pumilus spores","volume":"16","author":"Dorbani","year":"2025","journal-title":"Front. Microbiol."},{"issue":"5","key":"10.1016\/j.ejps.2026.107677_bib0003","doi-asserted-by":"crossref","first-page":"445","DOI":"10.5731\/pdajpst.2020.012385","article-title":"Contamination control strategy: implementation road map","volume":"75","author":"El Azab","year":"2021","journal-title":"PDa J. Pharm. Sci. Technol."},{"key":"10.1016\/j.ejps.2026.107677_bib0004","series-title":"Volume 4\u2013Guidelines For Good Manufacturing Practice for Medicinal Products","year":"2026"},{"key":"10.1016\/j.ejps.2026.107677_bib0005","unstructured":"European Pharmacopoeia (Ph. Eur.) 11th Edition. 2023."},{"issue":"3","key":"10.1016\/j.ejps.2026.107677_bib0006","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jhin.2010.12.006","article-title":"Airborne hydrogen peroxide for disinfection of the hospital environment and infection control: a systematic review","volume":"78","author":"Falagas","year":"2011","journal-title":"J. Hosp. Infect."},{"key":"10.1016\/j.ejps.2026.107677_bib0007","unstructured":"GAMP 5: A risk-based approach to compliant GxP computerized systems. 2026."},{"issue":"6","key":"10.1016\/j.ejps.2026.107677_bib0008","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1089\/ten.teb.2018.0114","article-title":"Establishing a current good manufacturing practice facility for biomaterials and biomolecules in an academic medical center","volume":"24","author":"Greenberg-Worisek","year":"2018","journal-title":"Tissue Eng. Part B Rev."},{"issue":"16","key":"10.1016\/j.ejps.2026.107677_bib0009","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1056\/NEJMhpr063086","article-title":"FDA regulation of stem-cell-based therapies","volume":"355","author":"Halme","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2026.107677_bib0010","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.copbio.2020.05.005","article-title":"Challenges and advantages of cell therapy manufacturing under good manufacturing practices within the hospital setting","volume":"65","author":"Iancu","year":"2020","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.ejps.2026.107677_bib0011","series-title":"Harmonised Tripartite Guideline Q10: Pharmaceutical Quality System","year":"2008"},{"key":"10.1016\/j.ejps.2026.107677_bib0012","unstructured":"ISO 14644-1:1999, Cleanrooms and associated controlled enviroments - part 1: classification of air cleanliness. 1999."},{"key":"10.1016\/j.ejps.2026.107677_bib0013","unstructured":"ISO 14644-5:2004 \u2013 cleanrooms and associated controlled environments \u2013 part 5: operations. 2004."},{"key":"10.1016\/j.ejps.2026.107677_bib0014","unstructured":"ISO 14644-1:2015 \u2013 classification of air cleanliness by particle concentration. 2015."},{"key":"10.1016\/j.ejps.2026.107677_bib0015","series-title":"ISO 18593:2018 Microbiology of the Food Chain \u2014 Horizontal methods For Surface Sampling","year":"2018"},{"issue":"5","key":"10.1016\/j.ejps.2026.107677_bib0016","first-page":"330","article-title":"Isolation and characterization of the environmental bacterial and fungi contamination in a pharmaceutical unit of mesenchymal stem cell for clinical use","volume":"40","author":"Mart\u00edn","year":"2012","journal-title":"Biol. J. Int. Assoc. Biol. Stand"},{"issue":"9","key":"10.1016\/j.ejps.2026.107677_bib0017","first-page":"1047","article-title":"Evaluating ecological impact and sustainability in the manufacturing of advanced therapies: comparative analysis of greenhouse gas emissions in the production of ATMPs in open and closed systems","volume":"10","author":"Pinnetta","year":"2023","journal-title":"Bioeng. Basel. Switz."},{"key":"10.1016\/j.ejps.2026.107677_bib0018","series-title":"Failure Modes and Effects Analysis (FMEA) Tool","year":"2017"},{"key":"10.1016\/j.ejps.2026.107677_bib0019","unstructured":"Regulation (EC) No 1394\/2007 of the European parliament and of the council of 13 November 2007 on advanced therapy medicinal products."},{"issue":"3","key":"10.1016\/j.ejps.2026.107677_bib0020","first-page":"22","article-title":"The environmental monitoring program in a GMP environment","volume":"14","author":"Sutton","year":"2010","journal-title":"J. GXP Compl."},{"issue":"11","key":"10.1016\/j.ejps.2026.107677_bib0021","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.jcyt.2024.06.008","article-title":"Environmental monitoring of current good manufacturing practices cleanroom facilities for manufacturing of cellular therapy products in an academic hospital setting","volume":"26","author":"Tanna","year":"2024","journal-title":"Cytotherapy"},{"key":"10.1016\/j.ejps.2026.107677_bib0022","unstructured":"The Rules Governing Medicinal Products in the European Union, Volume 4: EU guidelines to good manufacturing practice medicinal products for human and veterinary use: annex 1 manufacture of sterile medicinal products, August 2023."},{"issue":"4","key":"10.1016\/j.ejps.2026.107677_bib0023","doi-asserted-by":"crossref","first-page":"408","DOI":"10.5731\/pdajpst.2019.010975","article-title":"Environmental and Personnel Monitoring programs-a risk-based case study of cutibacterium acnes","volume":"74","author":"Tidswel","year":"2020","journal-title":"PDa J. Pharm. Sci. Technol."},{"issue":"7","key":"10.1016\/j.ejps.2026.107677_bib0024","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2217\/rme-2017-0051","article-title":"Challenges of running a GMP facility for regenerative medicine in a public hospital","volume":"12","author":"Vigan\u00f2","year":"2017","journal-title":"Regener. Med."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726002514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726002514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:53:37Z","timestamp":1793123617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098726002514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":24,"alternative-id":["S0928098726002514"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107677","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Addressing good manufacturing practice challenges in hospital advanced therapy medical product facilities: A risk-based environmental microbiological monitoring approach","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107677","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107677"}}